Gisela Gili

Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial

Alberto M. Borobia, Antonio J. Carcas, Mayte Pérez‐Olmeda et al. · The Lancet · 2021 · 384 citations · Full text

Biomarker kinetics in the prediction of VAP diagnosis: results from the BioVAP study

Pedro Póvoa, Ignacio Martín‐Loeches, Paula Ramírez et al. · Annals of Intensive Care · 2016 · 86 citations · Full text

Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension

Renato Mantegazza, Gil I. Wolfe, Srikanth Muppidi et al. · Neurology · 2020 · 74 citations · Full text

Thenar oxygen saturation measured by near infrared spectroscopy as a noninvasive predictor of low central venous oxygen saturation in septic patients

Jaume Mesquida, Jordi Masip, Gisela Gili et al. · Intensive Care Medicine · 2009 · 58 citations

Septic Patients, Infrared Spectroscopy, Physiology +10

Ward mortality in patients discharged from the ICU with tracheostomy may depend on patient’s vulnerability

Rafael Fernández, N. Bacelar, Gonzalo Hernández et al. · Intensive Care Medicine · 2008 · 43 citations

Critical Care Management, Ward Mortality, Critical Care Medicine +7